speb/financial-data huggingface dataset:
BMRN income_statement (annual, 2023-12-31) — +Total Revenue: 2419226000.00
BMRN balance_sheet (annual, 2023-12-31) — Accounts Payable: 315509000.00
BMRN balance_sheet (annual, 2023-12-31) — Accounts Receivable: 633704000.00
BMRN balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -867089000.00
BMRN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 5611562000.00
BMRN income_statement (annual, 2023-12-31) — Amortization: 62211000.00
BMRN income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 62211000.00
BMRN cash_flow (annual, 2023-12-31) — Amortization Of Securities: -9228000.00
BMRN cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 38608000.00
BMRN balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 611135000.00
BMRN income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
BMRN income_statement (annual, 2023-12-31) — Basic Average Shares: 187834000.00
BMRN income_statement (annual, 2023-12-31) — Basic EPS: 0.89
BMRN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 724531000.00
BMRN balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 860807000.00
BMRN cash_flow (annual, 2023-12-31) — Capital Expenditure: -107611000.00
BMRN balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 8779000.00
BMRN balance_sheet (annual, 2023-12-31) — Capital Stock: 189000.00
BMRN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 755127000.00
BMRN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 1073810000.00
BMRN balance_sheet (annual, 2023-12-31) — Cash Equivalents: 525451000.00
BMRN balance_sheet (annual, 2023-12-31) — Cash Financial: 229676000.00
BMRN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -18727000.00
BMRN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -111244000.00
BMRN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 159259000.00
BMRN cash_flow (annual, 2023-12-31) — Change In Account Payable: 68853000.00
BMRN cash_flow (annual, 2023-12-31) — Change In Inventory: -157058000.00
BMRN cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -81484000.00
BMRN cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 23585000.00
BMRN cash_flow (annual, 2023-12-31) — Change In Payable: 68853000.00
BMRN cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 68853000.00
BMRN cash_flow (annual, 2023-12-31) — Change In Receivables: -190435000.00
BMRN cash_flow (annual, 2023-12-31) — Change In Working Capital: -336539000.00
BMRN cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -190435000.00
BMRN cash_flow (annual, 2023-12-31) — Changes In Cash: 29288000.00
BMRN balance_sheet (annual, 2023-12-31) — Common Stock: 189000.00
BMRN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 4951549000.00
BMRN balance_sheet (annual, 2023-12-31) — Construction In Progress: 100013000.00
BMRN income_statement (annual, 2023-12-31) — Cost Of Revenue: 532062000.00
BMRN balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 6190000.00
BMRN balance_sheet (annual, 2023-12-31) — Current Assets: 2956088000.00
BMRN balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 8779000.00
BMRN balance_sheet (annual, 2023-12-31) — Current Debt: 493877000.00
BMRN balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 502656000.00
BMRN balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 4620000.00
BMRN balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 4620000.00
BMRN balance_sheet (annual, 2023-12-31) — Current Liabilities: 1177024000.00
BMRN cash_flow (annual, 2023-12-31) — Deferred Income Tax: -44981000.00
BMRN cash_flow (annual, 2023-12-31) — Deferred Tax: -44981000.00
BMRN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 104386000.00
BMRN income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 62211000.00
BMRN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 104386000.00
BMRN income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 62211000.00
BMRN income_statement (annual, 2023-12-31) — Diluted Average Shares: 191595000.00
BMRN income_statement (annual, 2023-12-31) — Diluted EPS: 0.87
BMRN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 167645000.00
BMRN income_statement (annual, 2023-12-31) — EBIT: 205898000.00
BMRN income_statement (annual, 2023-12-31) — EBITDA: 310284000.00
BMRN cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 1308000.00
BMRN cash_flow (annual, 2023-12-31) — End Cash Position: 755127000.00
BMRN cash_flow (annual, 2023-12-31) — Financing Cash Flow: -18727000.00
BMRN balance_sheet (annual, 2023-12-31) — Finished Goods: 380372000.00
BMRN cash_flow (annual, 2023-12-31) — Free Cash Flow: 51648000.00
BMRN income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
BMRN balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -28788000.00
BMRN income_statement (annual, 2023-12-31) — General And Administrative Expense: 404000000.00
BMRN balance_sheet (annual, 2023-12-31) — Goodwill: 196199000.00
BMRN balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 490900000.00
BMRN balance_sheet (annual, 2023-12-31) — Gross PPE: 1933222000.00
BMRN income_statement (annual, 2023-12-31) — Gross Profit: 1887164000.00
BMRN cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 73312000.00
BMRN balance_sheet (annual, 2023-12-31) — Income Tax Payable: 2651000.00
BMRN income_statement (annual, 2023-12-31) — Interest Expense: 17335000.00
BMRN income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 17335000.00
BMRN income_statement (annual, 2023-12-31) — Interest Income: 58339000.00
BMRN income_statement (annual, 2023-12-31) — Interest Income Non Operating: 58339000.00
BMRN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 10303000.00
BMRN balance_sheet (annual, 2023-12-31) — Inventory: 1107183000.00
BMRN balance_sheet (annual, 2023-12-31) — Invested Capital: 6038521000.00
BMRN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -111244000.00
BMRN balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 611135000.00
BMRN balance_sheet (annual, 2023-12-31) — Investments And Advances: 611135000.00
BMRN balance_sheet (annual, 2023-12-31) — Land And Improvements: 117560000.00
BMRN balance_sheet (annual, 2023-12-31) — Leases: 58230000.00
BMRN balance_sheet (annual, 2023-12-31) — Long Term Debt: 593095000.00
BMRN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 593095000.00
BMRN cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
BMRN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 257935000.00
BMRN cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
BMRN balance_sheet (annual, 2023-12-31) — Net Debt: 331845000.00
BMRN cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 28446000.00
BMRN income_statement (annual, 2023-12-31) — Net Income: 167645000.00
BMRN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 167645000.00
BMRN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 167645000.00
BMRN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 167645000.00
BMRN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 167645000.00
BMRN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 167645000.00
BMRN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 167645000.00
BMRN cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -10920000.00
BMRN income_statement (annual, 2023-12-31) — Net Interest Income: 41004000.00
BMRN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -3633000.00
BMRN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
BMRN cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
BMRN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 41004000.00
BMRN cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -88080000.00
BMRN balance_sheet (annual, 2023-12-31) — Net PPE: 1066133000.00
BMRN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -96691000.00
BMRN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 4460649000.00
BMRN balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 1545809000.00
BMRN balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 1545809000.00
BMRN income_statement (annual, 2023-12-31) — Normalized EBITDA: 310284000.00
BMRN income_statement (annual, 2023-12-31) — Normalized Income: 167645000.00
BMRN cash_flow (annual, 2023-12-31) — Operating Cash Flow: 159259000.00
BMRN cash_flow (annual, 2023-12-31) — Operating Gains Losses: 28446000.00
BMRN income_statement (annual, 2023-12-31) — Operating Income: 185780000.00
BMRN income_statement (annual, 2023-12-31) — Operating Revenue: 2419226000.00
BMRN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 188598154.00
BMRN balance_sheet (annual, 2023-12-31) — Other Current Assets: 141391000.00
BMRN balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 493877000.00
BMRN balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 33853000.00
BMRN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -28788000.00
BMRN balance_sheet (annual, 2023-12-31) — Other Equity Interest: -9860000.00
BMRN income_statement (annual, 2023-12-31) — Other Gand A: 404000000.00
BMRN income_statement (annual, 2023-12-31) — Other Income Expense: -38215000.00
BMRN balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 294701000.00
BMRN cash_flow (annual, 2023-12-31) — Other Non Cash Items: 3823000.00
BMRN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 171538000.00
BMRN balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 119935000.00
BMRN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -38215000.00
BMRN balance_sheet (annual, 2023-12-31) — Other Payable: 110478000.00
BMRN balance_sheet (annual, 2023-12-31) — Other Properties: 538677000.00
BMRN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 318683000.00
BMRN balance_sheet (annual, 2023-12-31) — Payables: 428638000.00
BMRN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 434828000.00
BMRN balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 201067000.00
BMRN income_statement (annual, 2023-12-31) — Pretax Income: 188563000.00
BMRN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 69353000.00
BMRN balance_sheet (annual, 2023-12-31) — Properties: 0.00
BMRN cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
BMRN cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -10920000.00
BMRN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -868496000.00
BMRN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -96691000.00
BMRN balance_sheet (annual, 2023-12-31) — Raw Materials: 155704000.00
BMRN balance_sheet (annual, 2023-12-31) — Receivables: 633704000.00
BMRN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 489887000.00
BMRN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 104386000.00
BMRN cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
BMRN income_statement (annual, 2023-12-31) — Research And Development: 746773000.00
BMRN income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
BMRN balance_sheet (annual, 2023-12-31) — Retained Earnings: -621554000.00
BMRN cash_flow (annual, 2023-12-31) — Sale Of Investment: 864863000.00
BMRN income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 488400000.00
BMRN income_statement (annual, 2023-12-31) — Selling General And Administration: 892400000.00
BMRN balance_sheet (annual, 2023-12-31) — Share Issued: 188598154.00
BMRN income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
BMRN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 207099000.00
BMRN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 4951549000.00
BMRN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 4460649000.00
BMRN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BMRN income_statement (annual, 2023-12-31) — Tax Provision: 20918000.00
BMRN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.11
BMRN balance_sheet (annual, 2023-12-31) — Total Assets: 6841603000.00
BMRN balance_sheet (annual, 2023-12-31) — Total Capitalization: 5544644000.00
BMRN balance_sheet (annual, 2023-12-31) — Total Debt: 1095751000.00
BMRN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 4951549000.00
BMRN income_statement (annual, 2023-12-31) — Total Expenses: 2233446000.00
BMRN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1890054000.00
BMRN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3885515000.00
BMRN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 713030000.00
BMRN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 185774000.00
BMRN income_statement (annual, 2023-12-31) — Total Other Finance Cost: 594000.00
BMRN balance_sheet (annual, 2023-12-31) — Total Tax Payable: 2651000.00
BMRN income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
BMRN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BMRN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
BMRN balance_sheet (annual, 2023-12-31) — Work In Process: 571107000.00
BMRN balance_sheet (annual, 2023-12-31) — Working Capital: 1779064000.00
BMRN cash_flow (quarterly, 2024-09-30) — Change In Account Payable: 122280000.00
BMRN cash_flow (quarterly, 2024-09-30) — Change In Payable: 122280000.00
BMRN balance_sheet (quarterly, 2024-09-30) — Current Deferred Liabilities: 2346000.00
BMRN balance_sheet (quarterly, 2024-09-30) — Current Deferred Revenue: 2346000.00
BMRN cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: -494927000.00
BMRN cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: -494927000.00
BMRN cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: -494927000.00
BMRN cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 1141000.00
BMRN cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: -494927000.00
BMRN income_statement (annual, 2024-12-31) — +Operating Expense: 1799441000.00
BMRN income_statement (annual, 2024-12-31) — +Total Revenue: 2853915000.00
BMRN balance_sheet (annual, 2024-12-31) — Accounts Payable: 235403000.00
BMRN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 660535000.00
BMRN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -891791000.00
BMRN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 5802068000.00
BMRN income_statement (annual, 2024-12-31) — Amortization: 43257000.00
BMRN income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 43257000.00
BMRN cash_flow (annual, 2024-12-31) — Amortization Of Securities: -8345000.00
BMRN cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 19889000.00
BMRN balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 521238000.00
BMRN balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 521238000.00
BMRN income_statement (annual, 2024-12-31) — Average Dilution Earnings: 7327000.00
BMRN income_statement (annual, 2024-12-31) — Basic Average Shares: 190027000.00
BMRN income_statement (annual, 2024-12-31) — Basic EPS: 2.25
BMRN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 755127000.00
BMRN balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 892484000.00
BMRN balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 892484000.00
BMRN cash_flow (annual, 2024-12-31) — Capital Expenditure: -97418000.00
BMRN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 7574000.00
BMRN balance_sheet (annual, 2024-12-31) — Capital Stock: 191000.00
BMRN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 942842000.00
BMRN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1137706000.00
BMRN balance_sheet (annual, 2024-12-31) — Cash Equivalents: 613223000.00
BMRN balance_sheet (annual, 2024-12-31) — Cash Financial: 329619000.00
BMRN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -526447000.00
BMRN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 136491000.00
BMRN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 572841000.00
BMRN cash_flow (annual, 2024-12-31) — Change In Account Payable: -32240000.00
BMRN cash_flow (quarterly, 2024-12-31) — Change In Account Payable: -100259000.00
BMRN cash_flow (annual, 2024-12-31) — Change In Inventory: -63530000.00
BMRN cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -77478000.00
BMRN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 14761000.00
BMRN cash_flow (annual, 2024-12-31) — Change In Payable: -32240000.00
BMRN cash_flow (quarterly, 2024-12-31) — Change In Payable: -100259000.00
BMRN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -32240000.00
BMRN cash_flow (annual, 2024-12-31) — Change In Receivables: -57909000.00
BMRN cash_flow (annual, 2024-12-31) — Change In Working Capital: -216396000.00
BMRN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -57909000.00
BMRN cash_flow (annual, 2024-12-31) — Changes In Cash: 182885000.00
BMRN balance_sheet (annual, 2024-12-31) — Common Stock: 191000.00
BMRN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 5657990000.00
BMRN balance_sheet (annual, 2024-12-31) — Construction In Progress: 90271000.00
BMRN balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 90271000.00
BMRN income_statement (annual, 2024-12-31) — Cost Of Revenue: 580235000.00
BMRN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 7117000.00
BMRN balance_sheet (annual, 2024-12-31) — Current Assets: 3232427000.00
BMRN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 7574000.00
BMRN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 7574000.00
BMRN balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 1369000.00
BMRN balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 1369000.00
BMRN balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 1369000.00
BMRN balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 1369000.00
BMRN balance_sheet (annual, 2024-12-31) — Current Liabilities: 606988000.00
BMRN cash_flow (annual, 2024-12-31) — Deferred Income Tax: 56096000.00
BMRN cash_flow (annual, 2024-12-31) — Deferred Tax: 56096000.00
BMRN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 96426000.00
BMRN income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 43257000.00
BMRN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 96426000.00
BMRN income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 43257000.00
BMRN income_statement (annual, 2024-12-31) — Diluted Average Shares: 196708000.00
BMRN income_statement (annual, 2024-12-31) — Diluted EPS: 2.21
BMRN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 434186000.00
BMRN income_statement (annual, 2024-12-31) — EBIT: 554429000.00
BMRN income_statement (annual, 2024-12-31) — EBITDA: 650855000.00
BMRN cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 4830000.00
BMRN cash_flow (annual, 2024-12-31) — End Cash Position: 942842000.00
BMRN cash_flow (annual, 2024-12-31) — Financing Cash Flow: -526447000.00
BMRN balance_sheet (annual, 2024-12-31) — Finished Goods: 527634000.00
BMRN cash_flow (annual, 2024-12-31) — Free Cash Flow: 475423000.00
BMRN income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 10000000.00
BMRN income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 0.00
BMRN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 61653000.00
BMRN income_statement (annual, 2024-12-31) — General And Administrative Expense: 532300000.00
BMRN balance_sheet (annual, 2024-12-31) — Goodwill: 196199000.00
BMRN balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 451477000.00
BMRN balance_sheet (annual, 2024-12-31) — Gross PPE: 1934832000.00
BMRN income_statement (annual, 2024-12-31) — Gross Profit: 2273680000.00
BMRN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 57269000.00
BMRN balance_sheet (annual, 2024-12-31) — Income Tax Payable: 12567000.00
BMRN income_statement (annual, 2024-12-31) — Interest Expense: 12666000.00
BMRN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 12666000.00
BMRN income_statement (annual, 2024-12-31) — Interest Income: 74883000.00
BMRN income_statement (annual, 2024-12-31) — Interest Income Non Operating: 74883000.00
BMRN cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 10361000.00
BMRN cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 3707000.00
BMRN balance_sheet (annual, 2024-12-31) — Inventory: 1232653000.00
BMRN balance_sheet (annual, 2024-12-31) — Invested Capital: 6253128000.00
BMRN cash_flow (annual, 2024-12-31) — Investing Cash Flow: 136491000.00
BMRN balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 521238000.00
BMRN balance_sheet (annual, 2024-12-31) — Investments And Advances: 521238000.00
BMRN balance_sheet (annual, 2024-12-31) — Land And Improvements: 118214000.00
BMRN balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 118214000.00
BMRN balance_sheet (annual, 2024-12-31) — Leases: 44368000.00
BMRN balance_sheet (quarterly, 2024-12-31) — Leases: 44368000.00
BMRN balance_sheet (annual, 2024-12-31) — Long Term Debt: 595138000.00
BMRN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 595138000.00
BMRN cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -494987000.00
BMRN cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
BMRN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 246639000.00
BMRN balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 246639000.00
BMRN cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
BMRN cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -16753000.00
BMRN income_statement (annual, 2024-12-31) — Net Income: 426859000.00
BMRN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 426859000.00
BMRN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 426859000.00
BMRN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 426859000.00
BMRN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 426859000.00
BMRN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 426859000.00
BMRN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 426859000.00
BMRN cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -11994000.00
BMRN cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -769000.00
BMRN income_statement (annual, 2024-12-31) — Net Interest Income: 62217000.00
BMRN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 222768000.00
BMRN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -494987000.00
BMRN cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
BMRN cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -494987000.00
BMRN cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
BMRN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 62217000.00
BMRN cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -80737000.00
BMRN cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 11141000.00
BMRN cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
BMRN balance_sheet (annual, 2024-12-31) — Net PPE: 1043041000.00
BMRN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -85424000.00
BMRN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 5206513000.00
BMRN balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 1489366000.00
BMRN balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 1489366000.00
BMRN income_statement (annual, 2024-12-31) — Normalized EBITDA: 640855000.00
BMRN income_statement (annual, 2024-12-31) — Normalized Income: 418979927.42
BMRN cash_flow (annual, 2024-12-31) — Operating Cash Flow: 572841000.00
BMRN cash_flow (annual, 2024-12-31) — Operating Gains Losses: -26753000.00
BMRN income_statement (annual, 2024-12-31) — Operating Income: 474239000.00
BMRN income_statement (annual, 2024-12-31) — Operating Revenue: 2853915000.00
BMRN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 190761349.00
BMRN balance_sheet (annual, 2024-12-31) — Other Current Assets: 201533000.00
BMRN balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 13056000.00
BMRN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 61653000.00
BMRN balance_sheet (annual, 2024-12-31) — Other Equity Interest: -11227000.00
BMRN income_statement (annual, 2024-12-31) — Other Gand A: 532300000.00
BMRN income_statement (annual, 2024-12-31) — Other Income Expense: 5332000.00
BMRN balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 255278000.00
BMRN cash_flow (annual, 2024-12-31) — Other Non Cash Items: 23494000.00
BMRN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 251391000.00
BMRN balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 128824000.00
BMRN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -4668000.00
BMRN balance_sheet (annual, 2024-12-31) — Other Payable: 128758000.00
BMRN balance_sheet (annual, 2024-12-31) — Other Properties: 542856000.00
BMRN balance_sheet (quarterly, 2024-12-31) — Other Properties: 542856000.00
BMRN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 194864000.00
BMRN balance_sheet (annual, 2024-12-31) — Payables: 376728000.00
BMRN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 383845000.00
BMRN balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 202513000.00
BMRN income_statement (annual, 2024-12-31) — Pretax Income: 541763000.00
BMRN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 49277000.00
BMRN cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 7862000.00
BMRN balance_sheet (annual, 2024-12-31) — Properties: 0.00
BMRN balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
BMRN cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
BMRN cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -11994000.00
BMRN cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -769000.00
BMRN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -410250000.00
BMRN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -85424000.00
BMRN balance_sheet (annual, 2024-12-31) — Raw Materials: 154341000.00
BMRN balance_sheet (annual, 2024-12-31) — Receivables: 660535000.00
BMRN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 527066000.00
BMRN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 96426000.00
BMRN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -494987000.00
BMRN cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
BMRN income_statement (annual, 2024-12-31) — Research And Development: 747184000.00
BMRN income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
BMRN balance_sheet (annual, 2024-12-31) — Retained Earnings: -194695000.00
BMRN cash_flow (annual, 2024-12-31) — Sale Of Investment: 633018000.00
BMRN income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 476700000.00
BMRN income_statement (annual, 2024-12-31) — Selling General And Administration: 1009000000.00
BMRN balance_sheet (annual, 2024-12-31) — Share Issued: 190761349.00
BMRN income_statement (annual, 2024-12-31) — Special Income Charges: 10000000.00
BMRN income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
BMRN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 201571000.00
BMRN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 5657990000.00
BMRN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 5206513000.00
BMRN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 2120927.42
BMRN income_statement (annual, 2024-12-31) — Tax Provision: 114904000.00
BMRN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
BMRN balance_sheet (annual, 2024-12-31) — Total Assets: 6988940000.00
BMRN balance_sheet (annual, 2024-12-31) — Total Capitalization: 6253128000.00
BMRN balance_sheet (annual, 2024-12-31) — Total Debt: 602712000.00
BMRN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 5657990000.00
BMRN income_statement (annual, 2024-12-31) — Total Expenses: 2379676000.00
BMRN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1330950000.00
BMRN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 3756513000.00
BMRN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 723962000.00
BMRN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 484214000.00
BMRN income_statement (annual, 2024-12-31) — Total Other Finance Cost: 391000.00
BMRN balance_sheet (annual, 2024-12-31) — Total Tax Payable: 12567000.00
BMRN income_statement (annual, 2024-12-31) — Total Unusual Items: 10000000.00
BMRN income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
BMRN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 10000000.00
BMRN income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BMRN balance_sheet (annual, 2024-12-31) — Work In Process: 550678000.00
BMRN balance_sheet (annual, 2024-12-31) — Working Capital: 2625439000.00
BMRN income_statement (quarterly, 2025-03-31) — +Operating Expense: 369678000.00
BMRN income_statement (quarterly, 2025-03-31) — +Total Revenue: 745145000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 293751000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 739177000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -908188000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 5794302000.00
BMRN income_statement (quarterly, 2025-03-31) — Amortization: 4847000.00
BMRN income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 4847000.00
BMRN cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -1362000.00
BMRN cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 2967000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 506724000.00
BMRN income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 1833000.00
BMRN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 190967000.00
BMRN income_statement (quarterly, 2025-03-31) — Basic EPS: 0.97
BMRN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 942842000.00
BMRN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -16768000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 6309000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 192000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1048803000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1272335000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 612034000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Cash Financial: 436769000.00
BMRN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -38779000.00
BMRN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -28238000.00
BMRN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 174394000.00
BMRN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -2655000.00
BMRN cash_flow (quarterly, 2025-03-31) — Change In Inventory: -24335000.00
BMRN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -7951000.00
BMRN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 2069000.00
BMRN cash_flow (quarterly, 2025-03-31) — Change In Payable: -2655000.00
BMRN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -2655000.00
BMRN cash_flow (quarterly, 2025-03-31) — Change In Receivables: -57590000.00
BMRN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -90462000.00
BMRN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -57590000.00
BMRN cash_flow (quarterly, 2025-03-31) — Changes In Cash: 107377000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Common Stock: 192000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5793459000.00
BMRN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 151558000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 12022000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Current Assets: 3467905000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 6309000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6309000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 628213000.00
BMRN cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 28429000.00
BMRN cash_flow (quarterly, 2025-03-31) — Deferred Tax: 28429000.00
BMRN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 22069000.00
BMRN income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 4847000.00
BMRN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 22069000.00
BMRN income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 4847000.00
BMRN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 196474000.00
BMRN income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.95
BMRN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 187519000.00
BMRN income_statement (quarterly, 2025-03-31) — EBIT: 240952000.00
BMRN income_statement (quarterly, 2025-03-31) — EBITDA: 263021000.00
BMRN cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -1416000.00
BMRN cash_flow (quarterly, 2025-03-31) — End Cash Position: 1048803000.00
BMRN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -38779000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Finished Goods: 469363000.00
BMRN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 157626000.00
BMRN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 0.00
BMRN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 19151000.00
BMRN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 103600000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Goodwill: 196199000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 443545000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1940801000.00
BMRN income_statement (quarterly, 2025-03-31) — Gross Profit: 593587000.00
BMRN cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 10388000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 23942000.00
BMRN income_statement (quarterly, 2025-03-31) — Interest Expense: 2863000.00
BMRN income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2863000.00
BMRN income_statement (quarterly, 2025-03-31) — Interest Income: 19013000.00
BMRN income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 19013000.00
BMRN cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
BMRN balance_sheet (quarterly, 2025-03-31) — Inventory: 1274848000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 6389109000.00
BMRN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -28238000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 506724000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 506724000.00
BMRN cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
BMRN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 595650000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 595650000.00
BMRN cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
BMRN cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -10026000.00
BMRN income_statement (quarterly, 2025-03-31) — Net Income: 185686000.00
BMRN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 185686000.00
BMRN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 185686000.00
BMRN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 185686000.00
BMRN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 185686000.00
BMRN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 185686000.00
BMRN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 185686000.00
BMRN cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
BMRN income_statement (quarterly, 2025-03-31) — Net Interest Income: 16150000.00
BMRN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -11470000.00
BMRN cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
BMRN cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
BMRN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 16150000.00
BMRN cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -38779000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Net PPE: 1032613000.00
BMRN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -16768000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5349914000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 1460566000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1460566000.00
BMRN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 263021000.00
BMRN income_statement (quarterly, 2025-03-31) — Normalized Income: 185686000.00
BMRN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 174394000.00
BMRN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -10026000.00
BMRN income_statement (quarterly, 2025-03-31) — Operating Income: 223909000.00
BMRN income_statement (quarterly, 2025-03-31) — Operating Revenue: 745145000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 191755802.00
BMRN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 181545000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 15516000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 19151000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: -11177000.00
BMRN income_statement (quarterly, 2025-03-31) — Other Gand A: 103600000.00
BMRN income_statement (quarterly, 2025-03-31) — Other Income Expense: -1954000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 247346000.00
BMRN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -607000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 235654000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 129685000.00
BMRN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -1954000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Other Payable: 146446000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 223532000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Payables: 464139000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 476161000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 130227000.00
BMRN income_statement (quarterly, 2025-03-31) — Pretax Income: 238089000.00
BMRN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
BMRN cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
BMRN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -89274000.00
BMRN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -16768000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Raw Materials: 162492000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Receivables: 739177000.00
BMRN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 134336000.00
BMRN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 22069000.00
BMRN income_statement (quarterly, 2025-03-31) — Research And Development: 158731000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -9009000.00
BMRN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 77804000.00
BMRN income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 102500000.00
BMRN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 206100000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Share Issued: 191755802.00
BMRN income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
BMRN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 37700000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5793459000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5349914000.00
BMRN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BMRN income_statement (quarterly, 2025-03-31) — Tax Provision: 52403000.00
BMRN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
BMRN balance_sheet (quarterly, 2025-03-31) — Total Assets: 7147007000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6389109000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Total Debt: 601959000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5793459000.00
BMRN income_statement (quarterly, 2025-03-31) — Total Expenses: 521236000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1353548000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3679102000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 725335000.00
BMRN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 223893000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 23942000.00
BMRN income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
BMRN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BMRN balance_sheet (quarterly, 2025-03-31) — Work In Process: 642993000.00
BMRN balance_sheet (quarterly, 2025-03-31) — Working Capital: 2839692000.00
BMRN income_statement (quarterly, 2025-06-30) — +Operating Expense: 398454000.00
BMRN income_statement (quarterly, 2025-06-30) — +Total Revenue: 825410000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 310797000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 855855000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -931022000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 5851637000.00
BMRN income_statement (quarterly, 2025-06-30) — Amortization: 4846000.00
BMRN income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 4846000.00
BMRN cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -1355000.00
BMRN cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
BMRN balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 508592000.00
BMRN income_statement (quarterly, 2025-06-30) — Average Dilution Earnings: 1833000.00
BMRN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 191907000.00
BMRN income_statement (quarterly, 2025-06-30) — Basic EPS: 1.25
BMRN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1048803000.00
BMRN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -17367000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 7704000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 192000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1213816000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1432125000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 396563000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Cash Financial: 817253000.00
BMRN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -4603000.00
BMRN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -12592000.00
BMRN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 185271000.00
BMRN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 5766000.00
BMRN cash_flow (quarterly, 2025-06-30) — Change In Inventory: -48127000.00
BMRN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -20646000.00
BMRN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 3468000.00
BMRN cash_flow (quarterly, 2025-06-30) — Change In Payable: 5766000.00
BMRN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 5766000.00
BMRN cash_flow (quarterly, 2025-06-30) — Change In Receivables: -98534000.00
BMRN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -158073000.00
BMRN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -98534000.00
BMRN cash_flow (quarterly, 2025-06-30) — Changes In Cash: 168076000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Common Stock: 192000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 6027113000.00
BMRN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 150090000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 6446000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Current Assets: 3805332000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 7704000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 7704000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 684247000.00
BMRN cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 33342000.00
BMRN cash_flow (quarterly, 2025-06-30) — Deferred Tax: 33342000.00
BMRN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 18563000.00
BMRN income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 4846000.00
BMRN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 18563000.00
BMRN income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 4846000.00
BMRN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 197091000.00
BMRN income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.23
BMRN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 242365000.00
BMRN income_statement (quarterly, 2025-06-30) — EBIT: 300547000.00
BMRN income_statement (quarterly, 2025-06-30) — EBITDA: 319110000.00
BMRN cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -3063000.00
BMRN cash_flow (quarterly, 2025-06-30) — End Cash Position: 1213816000.00
BMRN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -4603000.00
BMRN balance_sheet (quarterly, 2025-06-30) — Finished Goods: 480894000.00